Plexus Surfaces Durable Cash Flows in FY2026 and Holds a Polished Path to Q1 2027

Ticker: PLXS • EPS figures and earnings surprise potential dominate the story, even as the company frames revenue forecast in its upcoming quarter.

Overview: the quarter, the year, and the stock-tick dance

Plexus Corp. (PLXS) reported results for its fiscal fourth quarter and fiscal year 2026, delivering a set of numbers that sit comfortably in the company’s historical band while still inviting the investor to parse the details behind the headlines. The press release maps a quarter with $1.427 billion in revenue, GAAP operating margin of 6.0%, and GAAP diluted earnings per share (EPS) of $2.51. On the non-GAAP side, the company cites a 6.7% operating margin and non-GAAP diluted EPS of $2.84, noting that stock-based compensation (SBC) expense of $0.33 per share is excluded in that figure. For the full year, Plexus reports revenue of $4.965 billion, GAAP operating margin of 5.3%, and GAAP diluted EPS of $7.41, with non-GAAP operating margin at 6.2% and non-GAAP diluted EPS of $8.97 (excluding $1.56 in SBC).

In the spirit of investor communications, Plexus also opened a gateway to the future: fiscal Q1 2027 guidance points to revenue between $1.410 billion and $1.460 billion, with GAAP diluted EPS in a range of $2.16 to $2.32 (including SBC of $0.30) and non-GAAP diluted EPS guidance of $2.46 to $2.62 (excluding SBC).\nThe numbers for Q4 are cleanly presented, but the story rests on whether the next period can sustain or accelerate the trajectory described by the company’s non-GAAP frame and its revenue forecast.

GAAP vs. non-GAAP: what the margins really say

The contrast between GAAP and non-GAAP results is a classic Plexus motif: a mid- to high-single-digit operating margin on a GAAP basis, shadowed by a slightly stronger margin when SBC is excluded. Specifically, Q4 GAAP operating margin at 6.0% is followed by a non-GAAP margin of 6.7%. The delta underscores the ongoing influence of stock-based compensation on net income—an expense that the non-GAAP frame consistently strips out to reveal operating efficiency and recurring cash-driven profitability.

For the full year, the GAAP story shows a 5.3% operating margin, compared with 6.2% on a non-GAAP basis. EPS parallels this theme: GAAP diluted EPS sits at $7.41 for FY2026, while non-GAAP diluted EPS lands at $8.97, with $1.56 of SBC excluded from the non-GAAP tally. In other words, the underlying operating strength is solid, but the needle on reported net income moves meaningfully when you strip SBC from the equation. It’s the accounting version of “the robot did the work, but the human price is in the SBC cake you bake.”

Guidance: what the next quarter could portend for the sector

The company’s forward-looking numbers show an expectation of continuity rather than a sudden leap. Q1 2027 revenue guidance is anchored between $1.410 billion and $1.460 billion. GAAP diluted EPS is guided to $2.16 to $2.32, which includes a known SBC expense of $0.30 per share; the corresponding non-GAAP diluted EPS guidance is $2.46 to $2.62, excluding stock-based compensation. The explicit inclusion of SBC in the GAAP outlook and its exclusion in the non-GAAP outlook highlights a pattern seen across the sector: management communicates the cash-driven operating strength separately from the compensation-related dilution that stock-based pay imposes on earnings reports.

From an investor-relations perspective, this framing matters. The “EPS consensus” narrative often hinges on how each party accounts for SBC and other non-operating items. Plexus’ numbers suggest a stable margin structure with modest top-line growth, but the EPS narrative depends on whether SBC costs are treated as an operating expense in the eyes of different analysts. In practice, this is the kind of guidance that can swing a beat or a miss depending on whether you’re looking through the GAAP or non-GAAP lens, and whether a given quarter’s SBC expense is unusually high or low relative to expectations.

Analysis: what this could portend for Plexus and peers

From a business health perspective, Plexus’ revenue level in the $1.4 billion range per quarter signals a mature, diversified EMS (electronics manufacturing service) footprint. The margin profile—lower on GAAP, healthier on non-GAAP—reflects a common industry theme: volume, mix, and the automating effect of scale keep margins in a manageable corridor even as SBC costs flow through the reports.

For peers in the space, the message is twofold. First, the durability of revenue around the $1.4 billion per-quarter mark reinforces the value of a broad customer base and the ability to weather demand oscillations in consumer electronics, automotive, and industrial segments. Second, the persistent impact of stock-based compensation on reported EPS highlights a broader market dynamic: management teams can point to strong operating leverage while investors discount headline EPS if SBC is large relative to profits. In other words, the sector should watch for how peers disclose and manage SBC, and how investors weigh GAAP vs non-GAAP earnings when comparing companies with different compensation programs.

If the demand environment remains constructive, Plexus’ Q1 guidance implies a steady cadence rather than a rebound to all-time highs. The company’s numbers imply a world where currency, supply constraints, and customer mix will continue to shape the margin trajectory. In this sense, Plexus’ results are less a dramatic hinge point and more a consistency test for a sector that thrives on high-mix, high-value manufacturing and the occasional SBC storytelling that investors listen to—sometimes skeptically, sometimes as a signal of long-term structure rather than near-term noise.

Takeaway: steady execution with SBC as the tax on “earnings strength”

The bottom line for PLXS remains a balance between real operating performance and the accounting footnote of stock-based compensation. The Q4 numbers—revenue $1.427B, GAAP EPS $2.51, non-GAAP EPS $2.84—provide a respectable display of throughput and margin discipline, while the FY2026 figures reinforce a durable margin framework when SBC is stripped away. The Q1 2027 revenue corridor of $1.410B–$1.460B, paired with GAAP EPS guidance of $2.16–$2.32 (including SBC) and non-GAAP EPS guidance of $2.46–$2.62 (excluding SBC), suggests Plexus remains on a path of stable profitability, contingent on the usual EMS factors: demand signaling, supplier reliability, and a consistent product mix.

For investors and sector peers, the key questions are: will the SBC tail wind remain manageable in the coming year, and can the company sustain a non-GAAP margin near 6% while growing revenue? If the answer is yes, the EPS narrative—both in GAAP and non-GAAP terms—could quietly compound, even if the stock’s daily moves look calm enough to soothe a jittery market. And if the market wants to test a potential earnings surprise, it’ll likely hinge on the balance between top-line execution and how aggressively SBC is treated in the reported numbers—an old plot twist, but a reliable one in the world of corporate earnings storytelling.